Covid-19 recoveries in India cross 60-lakh mark

Covid-19 recoveries in India cross 60-lakh mark As per the Ministry, Maharashtra (12,29,339 recoveries), Karnataka (5,61,610), Kerala (1,75,304), Andhra Pradesh (6,91,040) and Tamil Nadu (5,91,811) are the five states, respectively. https://ift.tt/eA8V8J

30 Minute HIIT Circuit with Alex Aust

30 Minute HIIT Circuit with Alex Aust

Take a break from your hustle and get moving with this 30 minute HIIT circuit with Under Armour trainer Alex Aust.

The post 30 Minute HIIT Circuit with Alex Aust appeared first on Under Armour.

Post-traumatic stress experienced by partners following miscarriage

Post-traumatic stress experienced by partners following miscarriage
Post-traumatic stress experienced by partners following miscarriage submitted by /u/shallah
[link] [comments]
https://ift.tt/36PzC5X October 10, 2020 at 02:19PM https://ift.tt/1R552o9

U.S., AstraZeneca strike deal for Covid-19 antibody treatment touted by Trump

U.S., AstraZeneca strike deal for Covid-19 antibody treatment touted by Trump The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population like those over 80 years old, the U.S. Department of Health and Human Services said. https://ift.tt/eA8V8J

Post-traumatic stress experienced by partners following miscarriage

Post-traumatic stress experienced by partners following miscarriage submitted by /u/shallah
[link] [comments]

Delhi:Over 2.3k healthcare staff infected by Covid, 75 dead; nurses worst hit

Delhi:Over 2.3k healthcare staff infected by Covid, 75 dead; nurses worst hit A report prepared by the committee of experts headed by Dr VK Paul from Niti Aayog has revealed that till date 2,324 healthcare workers have been affected by the novel coronavirus in the city. https://ift.tt/eA8V8J

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark New Delhi, Oct 9 : Drug firm Glenmark Pharmaceuticals on Friday said the addition of antiviral Umifenovir did not demonstrate any significant clinical benefit over Favipiravir alone in moderate COVID-19 patients. https://ift.tt/eA8V8J